• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用聚乳酸-羟基乙酸共聚物(PLGA)和二油酰基磷脂酰乙醇胺(DOTAP)佐剂在BALB/c小鼠中诱导针对结核分枝杆菌多组分抗原的强烈免疫反应。

Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.

作者信息

Khademi Farzad, Sahebkar Amirhossein, Fasihi-Ramandi Mahdi, Taheri Ramezan Ali

机构信息

Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

APMIS. 2018 Jun;126(6):509-514. doi: 10.1111/apm.12851.

DOI:10.1111/apm.12851
PMID:29924445
Abstract

A promising strategy for preventing illness and death caused by Mycobacterium tuberculosis (Mtb) is vaccination. In this study, we aimed to evaluate the capacity of a multicomponent vaccine comprising HspX/EsxS-fused protein, PLGA (poly (lactide-co-glycolide)) and DOTAP (1, 2-dioleoyl-3-trimethylammonium propane) in eliciting immune responses against Mtb in BALB/c mice. A preparation of PLGA nanoparticles (NPs) containing fused protein and DOTAP adjuvant was made using double emulsion solvent evaporation (w/o/w) and lipid film hydration methods, respectively. After three subcutaneous immunization of BALB/c mice with various formulations, ELISA technique was used to measure interferon-γ (IFN-γ) and interleukin-4 (IL-4) cytokines levels in splenocytes as well as serum anti-HspX/EsxS IgG1 and IgG2a titers. The results of the current study showed that PLGA/HspX/EsxS/DOTAP formulation was able to induce higher levels of FN-γ, IgG1, and IgG2a responses compared with BCG as the positive control, HspX/EsxS, HspX/EsxS/DOTAP and PLGA/HspX/EsxS formulations. Our results suggest that PLGA NPs, as delivery system, and DOTAP, as adjuvant, have a good potential to enhance immune responses against HspX/EsxS antigen after subcutaneous immunization of BALB/c mice.

摘要

预防结核分枝杆菌(Mtb)所致疾病和死亡的一种有前景的策略是接种疫苗。在本研究中,我们旨在评估一种由热休克蛋白X/分泌性蛋白EsxS融合蛋白、聚乳酸-羟基乙酸共聚物(PLGA)和1,2-二油酰基-3-三甲基铵丙烷(DOTAP)组成的多组分疫苗在BALB/c小鼠中引发抗Mtb免疫反应的能力。分别采用复乳溶剂蒸发法(w/o/w)和脂质膜水化法制备了含有融合蛋白和DOTAP佐剂的PLGA纳米颗粒(NPs)制剂。用不同制剂对BALB/c小鼠进行三次皮下免疫后,采用酶联免疫吸附测定(ELISA)技术检测脾细胞中干扰素-γ(IFN-γ)和白细胞介素-4(IL-4)细胞因子水平以及血清抗热休克蛋白X/分泌性蛋白EsxS IgG1和IgG2a滴度。本研究结果表明,与作为阳性对照的卡介苗(BCG)、热休克蛋白X/分泌性蛋白EsxS、热休克蛋白X/分泌性蛋白EsxS/DOTAP和PLGA/热休克蛋白X/分泌性蛋白EsxS制剂相比,PLGA/热休克蛋白X/分泌性蛋白EsxS/DOTAP制剂能够诱导更高水平的IFN-γ以及IgG1和IgG2a反应。我们的结果表明,PLGA纳米颗粒作为递送系统,DOTAP作为佐剂,在对BALB/c小鼠进行皮下免疫后,具有增强针对热休克蛋白X/分泌性蛋白EsxS抗原免疫反应的良好潜力。

相似文献

1
Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.使用聚乳酸-羟基乙酸共聚物(PLGA)和二油酰基磷脂酰乙醇胺(DOTAP)佐剂在BALB/c小鼠中诱导针对结核分枝杆菌多组分抗原的强烈免疫反应。
APMIS. 2018 Jun;126(6):509-514. doi: 10.1111/apm.12851.
2
A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity.结核分枝杆菌新型抗原与 MPLA 佐剂共包封于 PLGA:DDA 杂化纳米粒中,可刺激黏膜和系统免疫。
Microb Pathog. 2018 Dec;125:507-513. doi: 10.1016/j.micpath.2018.10.023. Epub 2018 Oct 21.
3
Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.结核分枝杆菌 HspX/EsxS 融合蛋白与 ISCOMATRIX 和 PLUSCOM 纳米佐剂在动物模型中经皮下给药后的免疫原性。
Microb Pathog. 2021 May;154:104842. doi: 10.1016/j.micpath.2021.104842. Epub 2021 Mar 21.
4
Enhancing immunogenicity of novel multistage subunit vaccine of using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration.使用聚乳酸-羟基乙酸共聚物:二油酰基磷脂酰乙醇胺混合纳米颗粒和单磷酰脂质 A 增强新型多阶段亚单位疫苗的免疫原性:皮下给药。
Iran J Basic Med Sci. 2019 Aug;22(8):893-900. doi: 10.22038/ijbms.2019.33962.8079.
5
Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection.微结构化脂质体亚单位疫苗可减轻结核分枝杆菌感染后的肺部炎症和细菌负荷。
Vaccine. 2014 Jul 23;32(34):4324-32. doi: 10.1016/j.vaccine.2014.06.037. Epub 2014 Jun 19.
6
Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.由抗原 Ag85B 和 HspX 组成的融合蛋白疫苗对小鼠结核分枝杆菌感染的免疫原性和保护效力。
Scand J Immunol. 2011 Jun;73(6):568-76. doi: 10.1111/j.1365-3083.2011.02531.x.
7
PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.基于聚乳酸-羟基乙酸共聚物(85:15)纳米颗粒递送重组L7/L12核糖体蛋白可保护小鼠免受流产布鲁氏菌544感染:一种有望替代传统佐剂的方法。
Mol Immunol. 2015 Dec;68(2 Pt A):272-9. doi: 10.1016/j.molimm.2015.09.011. Epub 2015 Oct 9.
8
The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.一种包含Ag85b、HspX以及CFP-10:ESAT-6融合蛋白并佐以CpG DNA和氢氧化铝的新型结核分枝杆菌疫苗的研发及初步评估。
FEMS Immunol Med Microbiol. 2010 Jun 1;59(1):42-52. doi: 10.1111/j.1574-695X.2010.00660.x. Epub 2010 Feb 17.
9
Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.融合分枝杆菌多阶段免疫原与Fc递送系统作为开发结核病疫苗的一种有前景的方法。
Infect Genet Evol. 2016 Apr;39:163-172. doi: 10.1016/j.meegid.2016.01.027. Epub 2016 Feb 4.
10
Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC).通过联合分子佐剂(CASAC)的掺入增强针对结核分枝杆菌 HSPX 抗原的免疫应答。
Mol Immunol. 2020 Jan;117:54-64. doi: 10.1016/j.molimm.2019.10.023. Epub 2019 Nov 15.

引用本文的文献

1
Protective Efficacy of Subunit Vaccine Expressing Rv0976c Against Tuberculosis.表达Rv0976c的亚单位疫苗对结核病的保护效力
Vaccines (Basel). 2025 Aug 17;13(8):872. doi: 10.3390/vaccines13080872.
2
Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review.基于纳米颗粒的佐剂在增强结核病疫苗接种方面的进展:综述
Vaccines (Basel). 2024 Nov 27;12(12):1335. doi: 10.3390/vaccines12121335.
3
Enhancement of the immunogenicity of a fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants as prophylactic vaccine after nasal administration in mice.
在小鼠鼻腔给药后,使用ISCOMATRIX和PLUSCOM纳米佐剂作为预防性疫苗增强融合蛋白的免疫原性。
Iran J Basic Med Sci. 2024;27(1):24-30. doi: 10.22038/IJBMS.2023.69295.15100.
4
The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges.颗粒系统在结核病预防和治疗中的应用:机遇与挑战
Microorganisms. 2023 Aug 2;11(8):1988. doi: 10.3390/microorganisms11081988.
5
CFP10-loaded PLGA nanoparticles as a booster vaccine confer protective immunity against .负载CFP10的聚乳酸-羟基乙酸共聚物纳米颗粒作为加强疫苗可赋予针对……的保护性免疫。
Bioimpacts. 2022;12(5):395-404. doi: 10.34172/bi.2022.23645. Epub 2022 Jun 8.
6
Therapeutic lipid-coated hybrid nanoparticles against bacterial infections.用于对抗细菌感染的治疗性脂质包被杂化纳米颗粒。
RSC Adv. 2020 Feb 27;10(14):8497-8517. doi: 10.1039/c9ra10921h. eCollection 2020 Feb 24.
7
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery.基于纳米载体的疫苗递送佐剂概述
Pharmaceutics. 2021 Mar 27;13(4):455. doi: 10.3390/pharmaceutics13040455.
8
Enhancing immunogenicity of novel multistage subunit vaccine of using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration.使用聚乳酸-羟基乙酸共聚物:二油酰基磷脂酰乙醇胺混合纳米颗粒和单磷酰脂质 A 增强新型多阶段亚单位疫苗的免疫原性:皮下给药。
Iran J Basic Med Sci. 2019 Aug;22(8):893-900. doi: 10.22038/ijbms.2019.33962.8079.